• Superoxide Dismutase Activity Assay: Practical Guide

  2026-09-16

  This guide shows how to use a colorimetric SOD Activity Assay to quantify antioxidant capacity while avoiding common reactive oxygen species measurement errors. It also explains when SOD activity complements, rather than replaces, mitochondrial H2O2 assays such as Amplex Red workflows.

• PP 3: A Rigorous Control for Src Assays

  2026-09-16

  1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine is more than a negative control: it helps distinguish Src-dependent biology from compound, vehicle, and pathway-level artifacts. This article develops an assay-centered framework using PP 3 alongside vascular ROS research and PP 2.

• WTAP–GLS Splicing Reprograms Ferroptosis in HCC

  2026-09-15

  The reference study identifies an EGFR–AKT–WTAP–GLS pathway that enables hepatocellular carcinoma cells to resist ferroptosis through m6A-dependent alternative splicing. Its integrated metabolomic, transcriptomic, molecular, in vivo, and clinical analyses connect glutamine utilization with redox protection and provide a mechanistic framework for studying ferroptosis-directed combination therapies.

• SIRT4 and Glutamine Metabolism in Liver Fibrosis

  2026-09-15

  Yin et al. identify SIRT4-mediated control of glutamate dehydrogenase as a metabolic brake on hepatic stellate cell activation and liver fibrosis. The study combines pharmacological GDH inhibition with SIRT4 manipulation in cellular and animal models, providing a mechanistic framework for targeting glutamine catabolism in fibrotic disease.

• Nitrocefin for Mechanistic β-Lactamase Profiling

  2026-09-14

  Nitrocefin is a chromogenic cephalosporin substrate for rapid β-lactamase activity measurement. This guide connects its yellow-to-red signal with enzyme heterogeneity, resistance interpretation, and practical assay design using insights from recent GOB-38 research.

• NSC-23766: A Rac GTPase Inhibitor in Cancer Research

  2026-09-14

  NSC-23766 is a selective Rac GTPase inhibitor for connecting Rac1-GEF activity with barrier integrity, apoptosis, migration, and tumor-cell behavior. This practical guide translates its biochemical potency, breast cancer combination data, and formulation properties into reproducible workflows and troubleshooting strategies.

• Cy3 Goat Anti-Human IgG: Assay-to-Insight

  2026-09-13

  Explore how the Cy3 Goat Anti-Human IgG (H+L) Antibody converts human antibody binding into interpretable fluorescence across immunofluorescence, tissue, flow cytometry, and ELISA workflows. This guide connects practical assay design with epitope-informed antibody research while defining the reagent’s translational limits.

• Otilonium Bromide: Cholinergic Research Workflows

  2026-09-12

  Build reproducible muscarinic blockade assays with Otilonium Bromide for smooth muscle, neuronal, and gastrointestinal motility studies. This guide combines practical dosing, controls, troubleshooting, and a careful translation of structure-based screening concepts without overstating antiviral relevance.

• Streptozotocin Workflows for Diabetes Research

  2026-09-11

  Build reproducible β-cell injury and experimental diabetes mellitus induction workflows with STZ, from fresh-solution handling through phenotype validation. Extend the model into painful diabetic neuropathy studies by pairing glycemic endpoints with spinal microglia, TBK1, and pyroptosis assays.

• Melittin in GBM: A Causal Assay Framework

  2026-09-11

  Melittin is a bioactive peptide for dissecting Gs/Gi signaling in glioblastoma research. This article presents a causal assay framework that separates signal transduction, migration, ferroptosis, and apoptosis readouts.

• Pseudo-UTP: Reliable mRNA Assay Workflows

  2026-09-10

  Learn how Pseudo-UTP (SKU B7972) can improve the design and interpretation of pseudouridine-containing mRNA workflows without conflating RNA chemistry with cell viability readouts. This scenario-based guide covers compatibility, handling, controls, data interpretation, and practical vendor-selection criteria.

• EdU Imaging Kits (Cy3) in Vascular Biology

  2026-09-10

  EdU Imaging Kits (Cy3) provide a precise way to connect S-phase DNA synthesis with vascular smooth muscle cell phenotypic switching. This article translates the LncDACH1 arteriovenous fistula study into an assay-design framework that distinguishes proliferation from broader cellular remodeling.

• Bacteroides fragilis and Gut–Brain Cholinergic Signaling

  2026-09-09

  A 2026 Neuron study identifies a colonic ChAT-positive cell–vagus–brain circuit through which Bacteroides fragilis suppresses seizures in mouse models and shows efficacy in pediatric refractory epilepsy. Its combination of microbiota analysis, neural recordings, pharmacological blockade, chemogenetics, and randomized clinical testing provides a mechanistic framework for microbiota-targeted antiseizure research.

• Tetracycline Hydrochloride: Assay Logic

  2026-09-09

  Tetracycline Hydrochloride is more than a routine bacteriostatic antibiotic: its ribosome-centered activity demands carefully matched endpoints, controls, and solvent handling. This guide develops an assay-design framework and contrasts bacterial translation inhibition with ROS-driven cancer-cell death without conflating the two mechanisms.

• Alfuzosin HCl: Mechanism and BPH Research

  2026-09-08

  Alfuzosin HCl is a functionally uroselective α1 adrenoceptor antagonist that reduces prostate, bladder-neck, and urethral smooth-muscle tone in benign prostatic hyperplasia. Its clinical pharmacology, formulation parameters, solubility, and assay ranges support both translational and analytical BPH research.

7950 records 1/530 page Next 12345 下5页 Last page